Heart Failure 2024: Cutting-edge science and stimulating discussions in heart failure management

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 61 sec. here
  • 8 min. at publisher
  • 📊 Quality Score:
  • News: 45%
  • Publisher: 71%

Heart News

Heart Failure,Cardiology,Hospital

Cutting edge science and stimulating discussions in heart failure management are in store at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC).

Apr 29 2024European Society of Cardiology Cutting-edge science and stimulating discussions in heart failure management are in store at Heart Failure 2024, a scientific congress of the European Society of Cardiology .

Heart Failure is a life-threatening syndrome affecting more than 64 million people worldwide. Up to one in three patients die within one year of hospital admission and 50-75% die within five years of admission. With such an important topic, what updates can we expect from Heart Failure 2024? There is some evidence that women may be less often treated with all recommended treatments. We need to understand why this happens. Is it because women have different diseases?" Not to miss: state-of-the-art care delivery for heart failure patients using digital health. "Heart failure is a chronic condition that needs collaboration with patients over a long period of time," said Dr. Moura.

Also on the agenda: key opinion leaders will explore contemporary thinking on the diagnosis of heart failure in the community. "Heart failure is very frequently diagnosed when a patient is admitted to hospital with acute heart failure," said Professor Filippatos. "Avoiding hospitalisations is extremely important, as they negatively impact quality of life and survival. Early diagnosis in the community would allow medication to be started and ideally prevent admissions.

Heart Failure Cardiology Hospital Research Syndrome

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Study Finds Empagliflozin Does Not Significantly Reduce Heart Failure Hospitalizations or Death After Heart AttackThe use of the SGLT-2 inhibitor empagliflozin after a heart attack did not show a significant benefit in reducing overall heart failure hospitalizations or death from any cause, according to a study presented at the American College of Cardiology's Annual Scientific Session. However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack.
Source: NewsMedical - 🏆 19. / 71 Read more »

ESC Preventive Cardiology 2024: Delving into burning issues about heart disease and much moreThe hottest science in the prevention of heart disease awaits at ESC Preventive Cardiology 2024, a scientific congress of the European Society of Cardiology (ESC).
Source: NewsMedical - 🏆 19. / 71 Read more »

Inter-atrial shunts may benefit some heart failure patients while harming others, trial findsInter-atrial shunts—investigational devices that create a small pathway for blood to pass from the left to the right side of the heart in order to improve heart failure symptoms and outcomes—may be beneficial to heart failure patients with reduced left ventricular ejection fraction (LVEF) but harmful or even deadly for heart failure patients with...
Source: medical_xpress - 🏆 101. / 51 Read more »

Gains in heart failure mortality have been erasedDeclines in heart failure-related mortality from 1999 to 2012 were entirely reversed from 2012 to 2021, according to a research letter published online April 24 in JAMA Cardiology.
Source: medical_xpress - 🏆 101. / 51 Read more »

Diabetes drug shows promise for the treatment of acute heart failureA multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death.
Source: medical_xpress - 🏆 101. / 51 Read more »

Unveiling immune features of heart failure paves the way for targeted therapiesIn a recent study published in the Science Bulletin, researchers comprehensively examined the composition and phenotypic features of myeloid cells in human failing hearts at a single-cell level, offering valuable insights into potential targets for monitoring and treating cardiac inflammation in heart failure.
Source: medical_xpress - 🏆 101. / 51 Read more »